7 – Financial result (XLS:) Download 1st half Million € 2018 2017 Dividends and similar income 16 19 Income from the disposal of shareholdings 11 1 Income from profit transfer agreements 1 3 Income from tax allocation to shareholdings − 1 Income from other shareholdings 28 24 Expenses from loss transfer agreements (11) (10) Write-downs on / losses from the sale of shareholdings − (3) Expenses from other shareholdings (11) (13) Net income from shareholdings 17 11 Interest income from cash and cash equivalents 77 101 Interest and dividend income from securities and loans 31 11 Interest income 108 112 Interest expenses (257) (290) Interest result (149) (178) Net interest income from overfunded pension plans and similar obligations 1 1 Income from the capitalization of borrowing costs 21 37 Miscellaneous financial income − − Other financial income 22 38 Write-downs on / losses from the disposal of securities and loans (13) − Net interest expense from underfunded pension plans and similar obligations (69) (88) Net interest expense from other long-term personnel obligations (1) − Unwinding the discount on other noncurrent liabilities (16) (19) Miscellaneous financial expenses (179) (90) Other financial expenses (278) (197) Other financial result (256) (159) Financial result (388) (326) Net income from shareholdings in the first half of 2018 exceeded the prior-year figure by €6 million. Income from the disposal of shareholdings arose from the transfer of Metanomics Health GmbH to BIOCRATES Life Sciences AG, Innsbruck, Austria, in January 2018. The interest result rose by €29 million in the first half of 2018, from minus €178 million to minus €149 million. The interest expense declined year on year, mainly as a result of more favorable refinancing conditions. Compared with the prior-year period, income from the capitalization of construction period interest decreased considerably as major investment projects have since started operations. The net interest expense from underfunded pension plans and similar obligations declined year on year as a result of the reduced net defined benefit liability as of January 1, 2018. Other financial expenses rose, primarily as a result of higher expenses from hedging transactions. back next